The weight-loss
peptide pen company.
Retatrutide, Cagrilintide, AOD-9604 — the GLP-1 and metabolic compounds at the heart of modern weight-loss research, shipped as prefilled, dose-accurate pens. No vials, no bac water, no dose math. Pull the cap, dial, research.
- Up to
- 100 mg / pen
- HPLC purity
- ≥99.0%
- From
- $11.63 / mg
- Resolution
- 0.1 mg
Compounds, dose, purity, $/mg
Retatrutide
Reta- Dose
- 30 mg
- Purity
- —
- $ / mg
- $11.63/mg
Triple GIP/GLP-1/glucagon receptor agonist research peptide — the most-anticipated next-generation metabolic compound, in a Vivaprime prefilled pen.
AOD-9604
AOD- Dose
- 30 mg
- Purity
- —
- $ / mg
- $8.30/mg
Modified hGH fragment 176–191 research peptide — widely studied in adipose-tissue and lipolytic-pathway research, in a Vivaprime prefilled pen.
5-Amino-1MQ
- Dose
- 100 mg
- Purity
- —
- $ / mg
- $2.79/mg
5-Amino-1MQ small-molecule NNMT-pathway inhibitor research compound — complements NAD+-salvage research. Vivaprime prefilled pen.
The GLP-1 weight-loss family
This category covers incretin-axis and metabolic-pathway compounds most commonly studied in energy-balance, glycemic-control, and adipose-signaling research. All are peptide or peptide-analog agonists acting on well-characterized receptors.
GLP-1 mono-agonist. The most-studied compound in the class; longest-running clinical dataset.
Triple agonist (GLP-1 + GIP + glucagon). Adds glucagon-receptor activity to further increase energy expenditure in preclinical models.
Long-acting amylin analog most notably co-studied with Semaglutide (the 'CagriSema' stack). Acts on amylin-receptor complexes — a different pathway from GLP-1/GIP, with additive effects on satiety signaling in published research.
Non-incretin comparator. GH-fragment (hGH 176–191) studied for lipolytic effects — a distinct class from the GLP-1-axis agonists above.
Small-molecule NNMT inhibitor studied in fat-cell metabolism and NAD-salvage research — a non-incretin complement to the GLP-1-axis compounds.
Full specs — dose, purity, $/mg, and per-batch COA — on every product page.
Research-grade.
Ready to use.
Most research suppliers ship vials that require reconstitution, calculation, and careful handling. We took that out of the equation. Every Vivaprime product is a sealed, precisely dosed prefilled pen, manufactured in a licensed EU facility and third-party tested by batch.
Every batch produced in a licensed EU pharmaceutical facility and released against pre-registered identity and purity specifications.
Independent laboratory analyzes identity, purity, and residual solvents on every production lot. Each COA is linked from its product page.
Insulated, temperature-logged shipments from our US warehouse. Same-week delivery across the continental US.
Operating under a Canadian federal corporation with active product liability insurance covering US claims.
The pen vs. the powder vial
Most research peptide suppliers ship lyophilized powder you have to reconstitute, measure, and inject. We ship the finished format — prefilled at spec, dose-accurate by design, lab-verified by batch.
Research use only · comparison for format, not efficacy
GLP-1 pens, not powder.
The weight-loss compounds researchers ask for — prefilled, lab-verified, and shipped cold-chain to your door.